Benchling for Cell Therapy R&D
Oct 20, 2021
Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The FDA approval of CAR T therapies has led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D complexities. This application note discusses how Benchling’s capabilities can solve these complexities and improve speed to milestone for organizations developing cell therapies.
Benchling for Cell Therapy R&D.pdf
- Radiolabelling Nucleic Acids with [γ-32P] ATP for Analytical Assays
- Generating and maintaining uniform 3D spheroids in long term cultures
- Noninvasive 3D imaging Using Optical Coherence Tomography
- Streamlined High Throughput Drug Screening with PrimeSurface® White 384 well 3D plates